Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-08

Clinical Trial Update: Cognitive Effects of Atomoxetine in Humans: Genetic Moderators [NA]

View source ↗

Summary

A completed clinical trial evaluated cognitive effects of atomoxetine in humans and examined genetic moderators in individuals with addiction. Results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

Sponsor: Yale University | Conditions: Addiction | NA | Status: COMPLETED | Results posted: 2017-06-08